Diagnosing metabolic syndrome in type 2 diabetes: Does it matter?

QJM: An International Journal of Medicine

Volumn 101, Issue 6, 2008, Pages 487-491

  Song, Soon H ^a   Hardisty, C A ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; NICOTINIC ACID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 44849084161     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn034     Document Type: Article

References (19)

1. Alberti K, Zimmett P. Definition, diagnosis and classification of diDbetes mellitus and its complication: Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Diabet Med 1998; 15:539-53.
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16:442-43.
4. Alberti KG, Zimmet P, Shaw J. The IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: A new worldwide definition. Lancet 2005; 366:1059-62.
5. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006; 49:49-55.
6. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions. Diabetes Care 2006; 29 145-47.
7. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in type 2 diabetic patients. The Valpolicella Heart Diabetes Study. Diabet Med 2006; 23 1268-74.
8. Monami M, Marchionni N, Masolli G, Mannussi E. IDF and ATPIII definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes, Obese Metab 2007; 9:350-53.
9. Lu B, Yang Y, Song X, Dong X, Zhang Z, Zhou L, et al. An evaluation of the international Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years ols and diagnosed with type 2 diabetes mellitus. Metabolism 2006; 55 1088-96.
10. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30:1206-11.
11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.
12. British Cardiac Society, British Hypertension Society, Diabetes UK, Heart UK, Primary Care Cardiovascular Society, Stroke Society. Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(Suppl V):v1-52.
13. Song SH, Hardisty CA. Cardiovascular risk profile of early and later onset type 2 diabetes. Practical Diabetes International 2007; 24:20-4.
14. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. Br Med J 2001; 322 1389-93.
15. Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes: Losing the relative protection of youth. Diabetes Care 2003; 26:2999-3005.
16. Hatunic M, Burns N, Finucane F, Mannion C, Nolan JJ. Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diabetes Vasc Dis Res 2005; 2:73-5.
17. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28:2289-304.
18. Hayashi T, Bokyo EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Minimum waist and visceral fat values for Identifying Japanese Americans at risk for the metabolic syndrome. Diabetes Care 2007; 30 120-27.
19. Mitsui R, Fukushima M, Nishi Y, Ueda N, Suzuki H, Taniguchi A, et al Factors responsible for deteriorating glucose intolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism 2006; 55 53-8.